Copanlisib (Aliqopa)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 16:30, 21 February 2015 by Jwarner (talk | contribs) (Created page with "==Mechanism of action== From [http://www.cancer.gov/drugdictionary?CdrID=653981 NCI Drug Dictionary]: A phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplasti...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mechanism of action

From NCI Drug Dictionary: A phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations.

Retrieved from "https://hemonc.org/w/index.php?title=Copanlisib_(Aliqopa)&oldid=7280"